Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-006502-42-IT
EUCTR2008-006502-42-IT
Active, not recruiting
Not Applicable

Early antibiotic treatment in pseudomonas aeruginosa eradication in cystic fibrosis patients: a randomised policentric study on two different protocols - #FFC17/2007

AZIENDA OSPEDALIERA MEYER0 sitesApril 7, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMedDRA version: 9.1Level: SOCClassification code 10038738Cystic fibrosis
DrugsTOBI*NEBUL 56F 1D 300MG/5ML

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
MedDRA version: 9.1Level: SOCClassification code 10038738
Sponsor
AZIENDA OSPEDALIERA MEYER
Status
Active, not recruiting
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2010
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA MEYER

Eligibility Criteria

Inclusion Criteria

  • •CF patients with new P. aeruginosa colonisation
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •pulmonary exacerbation, chronic infection by Gram negative roads

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Targeting antibiotics to pseudomonas aeruginosa in small airways (TAPAS) study in patients with cystic fibrosis: pharmacokinetics (PK)
NL-OMON27081Erasmus MC, Rotterdam10
Active, not recruiting
Phase 1
Clinical study to assess two different Pseudomonas aeruginosa eradication protocols in patients with cystic ¿brosiscystic fibrosisMedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2015-003881-96-ITAZIENDA OSPEDALIERO-UNIVERSITARIA MEYER112
Active, not recruiting
Phase 1
Pervention and Intervention of infections following Caesarean SectioSub-study 1: women delivering a child by caesarean section Sub-study 2: Women, who are hospitalized at the obstetrical ward for reoperation because of superficial or deep infection or haematoma after caesarean sectionTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
EUCTR2012-002068-29-DKJan Stener Joergensen2,844
Completed
Not Applicable
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy-C900 Multiple myelomaMultiple myelomaC900
PER-011-06EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),
Active, not recruiting
Phase 1
Trial of Therapy for the first pulmonary infection by Pseudomonas aeruginosa in Cystic Fibrosis.First Pseudomonas aeruginosa infection in patients with cystic fibrosisMedDRA version: 20.0Level: LLTClassification code 10021860Term: Infection Pseudomonas aeruginosaSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2009-012575-10-ITIVERSITY OF LIVERPOO286